EXCESSIVE DAYTIME SOMNOLENCE

Clinical trials for EXCESSIVE DAYTIME SOMNOLENCE explained in plain language.

Never miss a new study

Get alerted when new EXCESSIVE DAYTIME SOMNOLENCE trials appear

Sign up with your email to follow new studies for EXCESSIVE DAYTIME SOMNOLENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New One-Dose-Nightly pill tested for narcolepsy safety

Disease control Completed

This study tested the long-term safety and tolerability of a new, once-nightly version of a narcolepsy medication called FT218. It involved 184 people with narcolepsy, including those already taking a similar twice-nightly drug and those new to this type of treatment. The main go…

Matched conditions: EXCESSIVE DAYTIME SOMNOLENCE

Phase: PHASE3 • Sponsor: Avadel • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

EXCESSIVE DAYTIME SOMNOLENCE

Get alerted when new EXCESSIVE DAYTIME SOMNOLENCE trials appear

New One-Dose-Nightly pill tested for narcolepsy safety